First human trial tests new weapon against multiple cancers
Disease control
Completed
This early-stage study aimed to find a safe and effective dose of a new drug called TPST-1495, given alone or with an existing immunotherapy (pembrolizumab), for people with advanced solid tumors. It enrolled 89 adults with cancers like colorectal, lung, and head and neck cancer …
Phase: PHASE1 • Sponsor: Tempest Therapeutics • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC